Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pamela Young

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Respirology (Carlton, Vic.)|January 20, 2012
The six-minute walk test using forehead oximetry is reliable in the assessment of scleroderma lung diseaseMargaret Wilsher, Nicola Good, Raewyn Hopkins, et al.
Arthritis Research & Therapy|August 23, 2023
Efficacy of tofacitinib on enthesitis in patients with active psoriatic arthritis: analysis of pooled data from two phase 3 studiesPhilip J Mease, Ana-Maria Orbai, Oliver FitzGerald, et al.
The Western Journal of Emergency Medicine|August 18, 2022
An Intensive Approach to Improving Diversity, Equity, and Inclusion in an Academic Emergency DepartmentPamela Young, Dorcas Boahema Pinto, Shellie Asher, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
CYpHER: Catalytic extracellular targeted protein degradation with high potency and durable effectZachary R Crook, Gregory P Sevilla, Pamela Young, et al.
International Journal of Prisoner Health|October 11, 2021
Knowledge of the Good Samaritan Drug Overdose Act and possession of a naloxone kit among people recently released from prisonKatherine E McLeod, Jessica Xavier, Ali Okhowat, et al.
RMD Open|January 16, 2021
Impact of baseline body mass index on the efficacy and safety of tofacitinib in patients with psoriatic arthritisJon T Giles, Alexis Ogdie, Juan J Gomez Reino, et al.
Nature Communications|October 9, 2024
CYpHER: catalytic extracellular targeted protein degradation with high potency and durable effectZachary R Crook, Gregory P Sevilla, Pamela Young, et al.
ACR Open Rheumatology|September 10, 2020
Tofacitinib in Patients With Psoriatic Arthritis and Metabolic Syndrome: A Post hoc Analysis of Phase 3 StudiesChristopher T Ritchlin, Jon T Giles, Alexis Ogdie, et al.
International Journal of Prisoner Health|March 3, 2021
Supporting people leaving prisons during COVID-19: perspectives from peer health mentorsKatherine E McLeod, Kelsey Timler, Mo Korchinski, et al.
Rheumatology and Therapy|September 27, 2021
Exploring the Quality of Communication Between Patients with Psoriatic Arthritis and Physicians: Results of a Global Online SurveyLaura C Coates, Valderilio F Azevedo, Joseph C Cappelleri, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Respirology (Carlton, Vic.)|January 20, 2012
The six-minute walk test using forehead oximetry is reliable in the assessment of scleroderma lung diseaseMargaret Wilsher, Nicola Good, Raewyn Hopkins, et al.
Arthritis Research & Therapy|August 23, 2023
Efficacy of tofacitinib on enthesitis in patients with active psoriatic arthritis: analysis of pooled data from two phase 3 studiesPhilip J Mease, Ana-Maria Orbai, Oliver FitzGerald, et al.
The Western Journal of Emergency Medicine|August 18, 2022
An Intensive Approach to Improving Diversity, Equity, and Inclusion in an Academic Emergency DepartmentPamela Young, Dorcas Boahema Pinto, Shellie Asher, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
CYpHER: Catalytic extracellular targeted protein degradation with high potency and durable effectZachary R Crook, Gregory P Sevilla, Pamela Young, et al.
International Journal of Prisoner Health|October 11, 2021
Knowledge of the Good Samaritan Drug Overdose Act and possession of a naloxone kit among people recently released from prisonKatherine E McLeod, Jessica Xavier, Ali Okhowat, et al.
RMD Open|January 16, 2021
Impact of baseline body mass index on the efficacy and safety of tofacitinib in patients with psoriatic arthritisJon T Giles, Alexis Ogdie, Juan J Gomez Reino, et al.
Nature Communications|October 9, 2024
CYpHER: catalytic extracellular targeted protein degradation with high potency and durable effectZachary R Crook, Gregory P Sevilla, Pamela Young, et al.
ACR Open Rheumatology|September 10, 2020
Tofacitinib in Patients With Psoriatic Arthritis and Metabolic Syndrome: A Post hoc Analysis of Phase 3 StudiesChristopher T Ritchlin, Jon T Giles, Alexis Ogdie, et al.
International Journal of Prisoner Health|March 3, 2021
Supporting people leaving prisons during COVID-19: perspectives from peer health mentorsKatherine E McLeod, Kelsey Timler, Mo Korchinski, et al.
Rheumatology and Therapy|September 27, 2021
Exploring the Quality of Communication Between Patients with Psoriatic Arthritis and Physicians: Results of a Global Online SurveyLaura C Coates, Valderilio F Azevedo, Joseph C Cappelleri, et al.
Pageof 3